Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out the advertisement of prescriptions for injectable weight-loss drugs without ...

More and more Americans are turning to GLP-1 injections to lose weight. FOX 7 Austin's Rebecca Thomas spoke to an Austin physician to discuss.

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

ALBAWABA - The popular weight loss drug, Ozempic is causing panic among its users after experts revealed an alarming side ...

The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

Outside the game, commercials are a big part of Super Bowl Sunday. Companies pay large amounts of money for their ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.